GlassScriptPhysician profile
David Keith Parker
NPI 1306819040
$1,105.44
in general payments reported to CMS, 2019-2025
13 companies · $38.02 in 2025
The $38.02 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2020: $26.57 · 2021: $233 · 2022: $311 · 2023: $89.68 · 2024: $50.71 · 2025: $38.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $178.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $468.53 | 2021-2024 | Provenge |
| Intuitive Surgical, INC. | $146.81 | 2019 | |
| Cook Medical LLC | $94.90 | 2019 | |
| Kci USA, INC. | $93.72 | 2019-2023 | Snap, Activ.A.C. |
| Axonics, INC. | $81.45 | 2020-2022 | |
| Boston Scientific Corporation | $63.41 | 2019-2025 | General - Therapies |
| Bsn Medical INC | $37.10 | 2022 | |
| Abbvie INC. | $31.41 | 2023 | |
| Coloplast Corp | $24.44 | 2019 | |
| Karl Storz Endoscopy-America | $19.14 | 2019 | |
| Cashflow Solutions, LLC | $17.71 | 2024 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
| Merck Sharp & Dohme LLC | $17.07 | 2023 | Keytruda, Lynparza |
| Kerecis Limited | $9.75 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Parker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.